DK114689D0 - Magnetisk protein-konjugat, dets fremstilling og anvendelse - Google Patents

Magnetisk protein-konjugat, dets fremstilling og anvendelse

Info

Publication number
DK114689D0
DK114689D0 DK114689A DK114689A DK114689D0 DK 114689 D0 DK114689 D0 DK 114689D0 DK 114689 A DK114689 A DK 114689A DK 114689 A DK114689 A DK 114689A DK 114689 D0 DK114689 D0 DK 114689D0
Authority
DK
Denmark
Prior art keywords
production
conjugates
protein conjugate
protein
magnetic protein
Prior art date
Application number
DK114689A
Other languages
English (en)
Other versions
DK114689A (da
Inventor
Peter Hermentin
Reiner Doenges
Karlheinz Enssle
Roland Kurrle
Friedrich Robert Seiler
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK114689D0 publication Critical patent/DK114689D0/da
Publication of DK114689A publication Critical patent/DK114689A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/5434—Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
    • G01N2446/90—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids characterised by small molecule linker used to couple immunoreagents to magnetic particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK114689A 1988-03-10 1989-03-09 Magnetisk protein-konjugat, dets fremstilling og anvendelse DK114689A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3807904A DE3807904A1 (de) 1988-03-10 1988-03-10 Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
DK114689D0 true DK114689D0 (da) 1989-03-09
DK114689A DK114689A (da) 1989-09-11

Family

ID=6349346

Family Applications (1)

Application Number Title Priority Date Filing Date
DK114689A DK114689A (da) 1988-03-10 1989-03-09 Magnetisk protein-konjugat, dets fremstilling og anvendelse

Country Status (13)

Country Link
US (1) US5672687A (da)
EP (1) EP0332022B1 (da)
JP (1) JP2756297B2 (da)
KR (1) KR0142876B1 (da)
AT (1) ATE114667T1 (da)
AU (1) AU626540B2 (da)
CA (1) CA1339199C (da)
DE (2) DE3807904A1 (da)
DK (1) DK114689A (da)
ES (1) ES2064373T3 (da)
FI (1) FI102077B1 (da)
PT (1) PT89963B (da)
YU (1) YU49189A (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62197425A (ja) * 1986-02-25 1987-09-01 Toyo Soda Mfg Co Ltd 球状熱可塑性樹脂の製造方法
US5169754A (en) * 1990-10-31 1992-12-08 Coulter Corporation Biodegradable particle coatings having a protein covalently immobilized by means of a crosslinking agent and processes for making same
US5928958A (en) * 1994-07-27 1999-07-27 Pilgrimm; Herbert Superparamagnetic particles, process for their manufacture and usage
JP2003509680A (ja) * 1999-09-15 2003-03-11 ミライバイオ インコーポレイテッド 生物学的試料を処理する方法
EP1216258A1 (en) * 1999-09-28 2002-06-26 Universität Zürich Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis
DE10108857A1 (de) * 2001-02-14 2002-09-19 Hans-Dieter Hunger Bioaktive und biokompatible Konjugate mit magnetischen Eigenschaften und Verfahren zu deren Herstellung
EP1419786A1 (en) 2002-11-13 2004-05-19 Bracco Imaging S.p.A. Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof
US7164010B1 (en) 2005-09-28 2007-01-16 Academia Sinica Molecular magnetic protein
WO2012012737A2 (en) 2010-07-23 2012-01-26 The University Of Toledo Stable tregs and related materials and methods
CN113049811A (zh) * 2021-03-22 2021-06-29 深圳市亚辉龙生物科技股份有限公司 纳米磁珠包被物及其制备方法、检测试剂和检测试剂盒

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
NO155316C (no) * 1982-04-23 1987-03-11 Sintef Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
EP0109653A3 (en) * 1982-11-17 1986-01-29 Otsuka Pharmaceutical Co., Ltd. Process for preparing urokinase complex
JPS59134763A (ja) * 1983-01-20 1984-08-02 Eisai Co Ltd セクレチン関連誘導体
US4735796A (en) * 1983-12-08 1988-04-05 Gordon Robert T Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
NO163600C (no) * 1983-04-13 1990-06-27 Chem Fab Corp Forsterket fluorpolymer-komposittmateriale.
US4554088A (en) * 1983-05-12 1985-11-19 Advanced Magnetics Inc. Magnetic particles for use in separations
US4698302A (en) * 1983-05-12 1987-10-06 Advanced Magnetics, Inc. Enzymatic reactions using magnetic particles
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
US5002883A (en) * 1987-10-30 1991-03-26 Abbott Laboratories Covalent attachment of antibodies and antigens to solid phases using extended length heterobifunctional coupling agents

Also Published As

Publication number Publication date
PT89963A (pt) 1989-11-10
FI102077B (fi) 1998-10-15
ATE114667T1 (de) 1994-12-15
ES2064373T3 (es) 1995-02-01
DE58908667D1 (de) 1995-01-12
CA1339199C (en) 1997-08-05
JP2756297B2 (ja) 1998-05-25
EP0332022B1 (de) 1994-11-30
US5672687A (en) 1997-09-30
FI102077B1 (fi) 1998-10-15
AU3113589A (en) 1989-09-14
FI891098A (fi) 1989-09-11
DE3807904A1 (de) 1989-09-21
AU626540B2 (en) 1992-08-06
FI891098A0 (fi) 1989-03-08
KR0142876B1 (ko) 1998-07-01
EP0332022A2 (de) 1989-09-13
JPH02152997A (ja) 1990-06-12
DK114689A (da) 1989-09-11
PT89963B (pt) 1994-05-31
KR890014471A (ko) 1989-10-23
DE3807904C2 (da) 1992-02-20
EP0332022A3 (de) 1991-07-17
YU49189A (en) 1991-08-31

Similar Documents

Publication Publication Date Title
DK114689D0 (da) Magnetisk protein-konjugat, dets fremstilling og anvendelse
DK592489A (da) Glycosphingolipider, deres fremstillng og anvendelse
NZ241217A (en) Acid-labile linker compounds derived from maleamic acids.
ATE369878T1 (de) Träger-pharmaka-konjugate
GB1473541A (en) Vaccines processes for preparing the same applications thereof and hyperimmune sera prepared therefrom
ID17243A (id) Metode pembuatan komplek obat
DE3360371D1 (en) Process for the preparation of n-(tert. aminoalkyl)acryl amides
DK0403961T3 (da) Magnetiske protein-konjugater, fremgangsmåde til deres fremstilling og deres anvendelse
BG40318A3 (en) Method for preparing imunoglobuline derivatives of vindezine
DE69230970D1 (de) Bicylclische, polyazamakrocyclocarbonsäure-komplexe, konjugate, herstellung und verwendung als kontraststoffe
BR0213779A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina
DE59010462D1 (de) Neue Cobalamin-Säurehydrazide und davon abgeleitete Cobalamin-Konjugate
KR950701272A (ko) 펩티도글리칸 단량체(pgm)와 3가 금속의 착물, 이의 제조방법 및 그 용도
DK0474645T3 (da) Proteinkompleks
IE902195L (en) Magnetic protein conjugates
DK292584A (da) Biologisk aktive konjugater, deres fremstilling og anvendelse
KR860008985A (ko) 6- 아미노-3- 하이드라지노피리다진 유도체의 제조방법
IL140976A0 (en) Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
ES8306149A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-fenoti-zinsulfonamida.
DE19881189D2 (de) Verfahren zum Herstellen von weitgehend nebenwirkungsfreien Kontrastmitteln
NO911853L (no) Rensing av faktor xiii

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment